RINOFLUIMUCIL

This brand name is authorized in Brazil, Ecuador, Hong Kong SAR China, Romania.

Active ingredients

The drug RINOFLUIMUCIL contains a combination of these active pharmaceutical ingredients (APIs):

1	Acetylcysteine UNII WYQ7N0BPYC - ACETYLCYSTEINE
	Acetylcysteine is N-acetyl derivative of cysteine. Used as a mucolytic agent to reduce the viscosity of mucous secretions.
	Read more about Acetylcysteine
2	Tuaminoheptane UNII WZK5LN5CNW - TUAMINOHEPTANE SULFATE
	Read more about Tuaminoheptane

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
R01AB08	Tuaminoheptane	R Respiratory system → R01 Nasal preparations → R01A Decongestants and other nasal preparations for topical use → R01AB Sympathomimetics, combinations excl. corticosteroids
Discover more medicines within R01AB08
R01AX	Other nasal preparations	R Respiratory system → R01 Nasal preparations → R01A Decongestants and other nasal preparations for topical use
Discover more medicines within R01AX

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
BR	Câmara de Regulação do Mercado de Medicamentos	533801702176416, 533820080009507
EC	Agencia Nacional de Regulación, Control y Vigilancia Sanitaria	5142-MEE-0520
HK	Department of Health Drug Office	43293
RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	W53021001